Clin2
NCT06106529Possibly a fitRecruiting

Reducing hot flashes in women on hormone therapy for breast cancer

Breast CancerHot Flash Due to Medication

Treatments studied

Part of Cancer, Skin clinical trials.

This trial tests a new approach to reduce hot flashes in women taking hormone therapy for breast cancer. You may be able to join if you have at least 14 hot flashes a week and are not taking certain other treatments.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
260 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are a woman aged 18 or older, and you are pre-, peri-, or postmenopausal.
  • You have been on breast cancer hormone therapy (like tamoxifen or an aromatase inhibitor) for at least 4 weeks and plan to continue.
  • You have had hot flashes for at least 1 month, with 14 or more per week, and want to try medication for them.
  • You are not pregnant or breastfeeding.
  • You have not used antidepressants (like venlafaxine) or St. John's wort in the past year.
  • You have not taken gabapentin, calcium channel blockers, or oxybutynin recently for hot flashes.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05460819Not yet recruiting
Acupuncture to reduce hot flashes in breast cancer patients

This study looks at whether acupuncture can lessen hot flashes caused by hormone therapy in people with hormone receptor–positive breast cancer. It may help if you still have frequent hot flashes while taking (or recently started) hormone treatment.

Nanjing, Jiangsu
NCT05613504Not yet recruiting
Acupuncture for hot flashes in hormone-positive breast cancer

This study looks at whether acupuncture can reduce frequent, persistent hot flashes in people taking hormone therapy for hormone-receptor-positive breast cancer. It may help if your hot flashes are still happening despite ongoing treatment.

Nanjing, Jiangsu
NCT01530373Recruiting· Phase 2
Solifenacin vs clonidine to reduce breast cancer hot flashes

This trial compares two medicines—solifenacin and clonidine—to see which one better reduces hot flashes in people taking hormone-blocking cancer medicines. If you have frequent hot flashes, joining could help researchers find an effective option for symptom relief.

Little Rock, Arkansas
NCT07254429Recruiting· Phase 2
The Copenhagen Menopause Study for hot flash relief

This study tests a new treatment for women going through menopause who have frequent hot flashes. It aims to find a safe and effective way to reduce moderate to severe hot flashes.

Herlev
NCT07294339Not yet recruiting
Acupuncture for hot flashes in breast cancer patients

This trial tests whether acupuncture can reduce hot flashes in women with hormone receptor-positive breast cancer who are on hormone therapy. It aims to help manage this common side effect.

Beijing
NCT07077395Recruiting· Phase 2
Hot flash study to check heart health links

This study looks at how hot flashes in midlife women might be connected to heart disease risk. Researchers want to see if managing hot flashes can improve heart health.

Boston, Massachusetts

Hear when a new Breast cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.